EUVIMEDEUVIMED entdecken
Crossref

An oncogenic role for EBV ‐encoded BILF1 in nasopharyngeal carcinoma

Anna Kc Wong, Vinotheni Rajendran, Lucia Mundo, Wenbin Wei iD, Andrew I Bell, Max Robinson iD, Cristiana Bellan, Stefano Lazzi, Ciara Leahy, Pathmanathan Rajadurai, Yew Toong Liew, Narayanan Prepageran und 5 weitere

The Journal of Pathology · 2026-08 · 269 (4-5) · 412-422

DOI: 10.1002/path.70069 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Pathology, online erschienen am 07.05.2026. Verfasst von Anna Kc Wong und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Craniofacial Sciences and Oral Cancer Research & Coordinating Centre, Faculty of Dentistry, Universiti Malaya, Kuala Lumpur, M…. Hauptthemen laut MEDLINE: Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms, Herpesvirus 4, Human, Epstein-Barr Virus Infections. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: University of Malaya Impact-Oriented Interdisciplinary Research Grant Programme, Ministry of Higher Education, Malaysia, Akademi Sains Malaysia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

It is widely recognized that latent infection is the predominant mode of Epstein–Barr virus (EBV) infection in nasopharyngeal carcinoma (NPC) in which a specific set of latent genes is responsible for driving the development of the disease. However, the expression of these latent genes does not adequately explain the various transformed phenotypes of NPC cells. Using an established high‐throughput quantitative reverse transcription PCR array, we found that several EBV lytic genes were more widely expressed in primary NPC tissues than previously recognized. We focused on a lytic gene, BILF1 , which encodes a constitutively active G protein‐coupled receptor (GPCR). We showed that BILF1 was expressed in tumour cells from primary NPC tissues at both mRNA and protein levels, and in the absence of BZLF1 expression. RNA sequencing analysis of BILF1 ‐expressing immortalised nasopharyngeal epithelial (NPE) cells demonstrated that the profile of BILF1‐regulated genes significantly overlapped with gene signatures of micro‐dissected NPC, indicating that the expression of BILF1 is relevant to the pathogenesis of NPC. In accordance with these observations, pathway analysis of the transcriptome of BILF1 ‐expressing cells showed the involvement of BILF1 in key biological processes typically deregulated in NPC. To examine whether BILF1 expression influenced epithelial cell behaviour, functional studies showed that BILF1 enhanced cell proliferation, migration, invasion and colony formation. In addition, BILF1 increased AKT activation in NPE cells, which was responsible for the increase in cell migration. Taken together, our data convincingly point to an oncogenic role for BILF1 in NPC. © 2026 The Pathological Society of Great Britain and Ireland.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nasopharyngeal CarcinomaNasopharyngeal NeoplasmsHerpesvirus 4, HumanEpstein-Barr Virus InfectionsCell Line, TumorHumansRespiratory MucosaProto-Oncogene Proteins c-aktCell MovementGene Expression Regulation, NeoplasticHost-Pathogen InteractionsViral ProteinsReceptors, G-Protein-Coupled

Stichwörter der Autor:innen

AKT signallingBILF1G protein‐coupled receptornasopharyngeal carcinoma; Epstein–Barr virus; EBV lytic geneviral oncogenesis

Substanzen

BILF1 protein, Epstein-Barr virusProto-Oncogene Proteins c-aktViral ProteinsReceptors, G-Protein-Coupled

Autor:innen und Institutionen

  • Department of Oral and Craniofacial Sciences and Oral Cancer Research & Coordinating Centre, Faculty of Dentistry, Universiti Malaya, Kuala Lumpur, Malaysia.
  • Medical Biotechnology, University of Siena, Siena, Italy.
  • Limerick Digital Cancer Research Centre, School of Medicine, Bernal Institute, and Health Research Institute, University of Limerick, Limerick, Ireland.
  • Clinical and Molecular Medicine, Sapienza University, Rome, Italy.
  • Department of Biosciences, Durham University, Durham, UK.
  • Department of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.

ORCID-Profile: Wenbin Wei, Max Robinson, Kwok-Wai Lo, Ian C Paterson, Lee Fah Yap

Förderung

  • University of Malaya Impact-Oriented Interdisciplinary Research Grant Programme
  • Ministry of Higher Education, Malaysia
  • Akademi Sains Malaysia
  • Marie-Sklodowska Curie Actions Individual Fellowship (MSCA-IF), EU, Horizon 2020.
  • Sapienza University
  • Facoltà di Medicina e Psicologiaa, Sapienza Università di Roma

Zitieren

APA

Wong, A. K., Rajendran, V., Mundo, L., Wei, W., Bell, A. I., Robinson, M., Bellan, C., Lazzi, S., Leahy, C., Rajadurai, P., Liew, Y. T., Prepageran, N., Young, L. S., Lo, K. W., Murray, P. G., Paterson, I. C., & Yap, L. F. (2026). An oncogenic role for EBV ‐encoded BILF1 in nasopharyngeal carcinoma. The Journal of Pathology, 269(4-5), 412-422. https://doi.org/10.1002/path.70069

Vancouver

Wong AK, Rajendran V, Mundo L, Wei W, Bell AI, Robinson M, et al. An oncogenic role for EBV ‐encoded BILF1 in nasopharyngeal carcinoma. The Journal of Pathology. 2026;269(4-5):412-422. doi:10.1002/path.70069

BibTeX
@article{Wong2026,
  author = {Wong, Anna Kc and Rajendran, Vinotheni and Mundo, Lucia and Wei, Wenbin and Bell, Andrew I and Robinson, Max and Bellan, Cristiana and Lazzi, Stefano and Leahy, Ciara and Rajadurai, Pathmanathan and Liew, Yew Toong and Prepageran, Narayanan and Young, Lawrence S and Lo, Kwok-Wai and Murray, Paul G and Paterson, Ian C and Yap, Lee Fah},
  title = {An oncogenic role for EBV ‐encoded BILF1 in nasopharyngeal carcinoma},
  journal = {The Journal of Pathology},
  year = {2026},
  volume = {269},
  number = {4-5},
  pages = {412--422},
  doi = {10.1002/path.70069}
}
Kostenlos starten →